Optimisation of Embryonic and Larval ECG Measurement in Zebrafish for Quantifying the Effect of QT Prolonging Drugs
Open Access
- 8 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e60552
- https://doi.org/10.1371/journal.pone.0060552
Abstract
Effective chemical compound toxicity screening is of paramount importance for safe cardiac drug development. Using mammals in preliminary screening for detection of cardiac dysfunction by electrocardiography (ECG) is costly and requires a large number of animals. Alternatively, zebrafish embryos can be used as the ECG waveform is similar to mammals, a minimal amount of chemical is necessary for drug testing, while embryos are abundant, inexpensive and represent replacement in animal research with reduced bioethical concerns. We demonstrate here the utility of pre-feeding stage zebrafish larvae in detection of cardiac dysfunction by electrocardiography. We have optimised an ECG recording system by addressing key parameters such as the form of immobilization, recording temperature, electrode positioning and developmental age. Furthermore, analysis of 3 days post fertilization (dpf) zebrafish embryos treated with known QT prolonging drugs such as terfenadine, verapamil and haloperidol led to reproducible detection of QT prolongation as previously shown for adult zebrafish. In addition, calculation of Z-factor scores revealed that the assay was sensitive and specific enough to detect large drug-induced changes in QTc intervals. Thus, the ECG recording system is a useful drug-screening tool to detect alteration to cardiac cycle components and secondary effects such as heart block and arrhythmias in zebrafish larvae before free feeding stage, and thus provides a suitable replacement for mammalian experimentation.This publication has 57 references indexed in Scilit:
- Identification and Functional Characterization of Cardiac Pacemaker Cells in ZebrafishPLOS ONE, 2012
- Development and Validation of an Automated High-Throughput System for Zebrafish In Vivo ScreeningsPLOS ONE, 2012
- Flexible microelectrode arrays to interface epicardial electrical signals with intracardial calcium transients in zebrafish heartsBiomedical Microdevices, 2011
- The zebrafish heart regenerates after cryoinjury-induced myocardial infarctionBMC Developmental Biology, 2011
- Evolving Cardiac Conduction Phenotypes in Developing Zebrafish Larvae: Implications to Drug SensitivityZebrafish, 2010
- Visualizing voltage dynamics in zebrafish heartJournal Of Physiology-London, 2010
- Cardiac arrhythmia:in vivoscreening in the zebrafish to overcome complexity in drug discoveryExpert Opinion on Drug Discovery, 2010
- Blebbistatin Effectively Uncouples the Excitation-Contraction Process in Zebrafish Embryonic HeartCellular Physiology and Biochemistry, 2010
- Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3 , as Regulators of Myocardial RepolarizationCirculation, 2009
- Mammalian Peripheral Circadian Oscillators Are Temperature CompensatedJournal of Biological Rhythms, 2008